Literature DB >> 2117422

Echocardiographic abnormalities in type IV mucopolysaccharidosis.

R M John1, D Hunter, R H Swanton.   

Abstract

Cardiac involvement is well recognised in most forms of the mucopolysaccharidoses but there is poor documentation of abnormalities specific to Morquio's syndrome (type IV mucopolysaccharidosis). Ten patients with the classic form or type A Morquio's syndrome with a median age of 12.5 years underwent echocardiographic assessment. Abnormalities were detected in six (60%) cases with mitral valve involvement in five patients and aortic valve disease in four. One patient had severe mitral leaflet thickening to the point of mitral stenosis. Two patients had evidence for myocardial involvement by way of echocardiographic ventricular hypertrophy. The cardiac lesions were haemodynamically mild. A cardiac murmur was audible in only three of the six cases. It is concluded that there is a high prevalence of silent cardiac abnormalities in patients with Morquio's syndrome with predominantly left sided valve involvement. Echocardiography should be part of the assessment of these patients and bacterial endocarditis prophylaxis should be advised for those with cardiac abnormalities.

Entities:  

Mesh:

Year:  1990        PMID: 2117422      PMCID: PMC1792426          DOI: 10.1136/adc.65.7.746

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  The histology and histochemistry of gargoylism.

Authors:  I M DAWSON
Journal:  J Pathol Bacteriol       Date:  1954-04

2.  Mucopolysaccharidosis type IV as a cause of mitral stenosis in an adult.

Authors:  M A Ireland; D B Rowlands
Journal:  Br Heart J       Date:  1981-07

3.  Echocardiographic abnormalities in the mucopolysaccharide storage diseases.

Authors:  D M Gross; J C Williams; C Caprioli; B Dominguez; R R Howell
Journal:  Am J Cardiol       Date:  1988-01-01       Impact factor: 2.778

4.  Lifetime risk for patients with mitral valve prolapse of developing severe valve regurgitation requiring surgery.

Authors:  D E Wilcken; A J Hickey
Journal:  Circulation       Date:  1988-07       Impact factor: 29.690

  4 in total
  16 in total

1.  Widespread Vasculopathy in a Patient with Morquio A Syndrome.

Authors:  Adam W Powell; Michael D Taylor; T Andrew Burrow; Robert J Hopkin; Carlos E Prada; John L Jefferies
Journal:  Tex Heart Inst J       Date:  2017-12-19

Review 2.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

3.  Mortality in patients with morquio syndrome a.

Authors:  Christine Lavery; Chris Hendriksz
Journal:  JIMD Rep       Date:  2014-04-10

Review 4.  Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review.

Authors:  H Northover; R A Cowie; J E Wraith
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses.

Authors:  C F Wippermann; M Beck; D Schranz; R Huth; I Michel-Behnke; B K Jüngst
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

Review 6.  Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.

Authors:  Hira Peracha; Kazuki Sawamoto; Lauren Averill; Heidi Kecskemethy; Mary Theroux; Mihir Thacker; Kyoko Nagao; Christian Pizarro; William Mackenzie; Hironori Kobayashi; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji Orii; Tadao Orii; Toshiyuki Fukao; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2018-05-15       Impact factor: 4.797

7.  Cardiac involvement in mucopolysaccharidoses: effects of allogeneic bone marrow transplantation.

Authors:  M A Gatzoulis; A Vellodi; A N Redington
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

8.  Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI.

Authors:  Marion M M G Brands; Ingrid M Frohn-Mulder; Marloes L C Hagemans; Wim C J Hop; Esmee Oussoren; Wim A Helbing; Ans T van der Ploeg
Journal:  J Inherit Metab Dis       Date:  2012-01-26       Impact factor: 4.982

9.  Current and emerging management options for patients with Morquio A syndrome.

Authors:  Mohamed F Algahim; G Hossein Almassi
Journal:  Ther Clin Risk Manag       Date:  2013-02-11       Impact factor: 2.423

Review 10.  Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA.

Authors:  Christian J Hendriksz; Maisoon Al-Jawad; Kenneth I Berger; Sara M Hawley; Rebecca Lawrence; Ciarán Mc Ardle; C Gail Summers; Elizabeth Wright; Elizabeth Braunlin
Journal:  J Inherit Metab Dis       Date:  2012-02-23       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.